Vital signs: Variation among states in prescribing of opioid pain relievers and benzodiazepines-United States, 2012
Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines-United States, 2012. MMWR Morb Mortal Wkly Rep 2014; 63: 563-8.
Maternal treatment with opioid analgesics and risk for birth defects
Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011; 204: 314: e1-11.
Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States
Bateman BT, Hernandez-Diaz S, Rathmell JP, et al. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology 2014; 120: 1216-24.
Source of payment for the delivery: Births in a 33-state and District of Columbia reporting area, 2010
Curtin SC, Osterman MJ, Uddin SF, Sutton SR, Reed PR. Source of payment for the delivery: births in a 33-state and District of Columbia reporting area, 2010. Natl Vital Stat Rep 2013; 62: 1-20.
Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study
Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain 2008; 138: 440-9.
US Department of Justice, Drug Enforcement Administration. Federal register. Schedules of controlled substances: rescheduling of hydrocodone combination products from Schedule III to Schedule II; 79: 49661-82. Available at http://www. gpo. gov/fdsys/pkg/FR-2014-08-22/pdf/2014-19922. pdf.